TipRanks
Go Ultimate55% OFF

Genix Pharmaceuticals (GENX) Income Statement

Genix Pharmaceuticals Income Statement

Last quarter (Q3 2024), Genix Pharmaceuticals's total revenue was ―. In Q3, Genix Pharmaceuticals's net income was $-82.17K. See Genix Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementOct 23Oct 22Oct 21Oct 20Oct 19
―――――
$ 3.26K―――$ -45.69K
―――――
Depreciation and Amortization$ 547.42K$ 564.17K$ 536.61K$ 361.57K$ 253.00
$ -3.80M$ -497.69K$ -1.11M$ -353.21K$ -162.67K
$ -880.89K$ -1.03M$ -1.65M$ -715.21K$ -143.34K
―――――
―――――
$ -4.40M$ -1.07M$ -1.65M$ -718.66K$ -164.70K
Per Share Metrics
Basic EPS―――――
Diluted EPS―――――
Weighted Average Shares Outstanding―――――
Weighted Average Shares Outstanding (Diluted)―――――

Currency in USD

Genix Pharmaceuticals Earnings and Revenue History

-180K-120K-60K00 %0.4 %0.8 %1.2 %EarningsProfit Margin2019RevenueEarningsProfit Margin